HEALTH● LOWAug 10 · Aug 10, 2026, 4:59 PM
Tonix outlines TNX-4800 Phase II with ~3,300 participants while scaling TONMYA to ~150 reps by September
Seeking Alpha Tech
Tonix Pharmaceuticals has outlined plans for its TNX-4800 Phase II clinical trial involving approximately 3,300 participants, while also planning to scale its TONMYA sales force to about 150 representatives by September. This indicates key operational and research developments for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoReturn of Ebola: Triumph of 2014, test of 2026Vanguard NigeriaHEALTH1h agoEby promises Langley long - term care facility | The Interior Newsinterior-news.com · CanadaHEALTH2h agoA Space , Filled : An Interview with Panhandle PBS Filmmaker Devin Singleton about His Documentary Series on Suicide Losshppr.org · United StatesHEALTH2h agoSecond raccoon with rabies found in Westlake Villagedailynews.com · United States